Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. BioSan Laboratories, Inc.
WARNING LETTER
•BioSan Laboratories, Inc.•January 25, 2011

BioSan Laboratories, Inc. – FDA Warning Letter, Jan 25, 2011

Record Details

An FDA inspection of BioSan Laboratories, Inc. (Dec 2010 - Jan 2011) identified significant Current Good Manufacturing Practice (cGMP) violations for dietary supplements, leading to products like Women Over 40 One Daily and Adrenal Response being deemed adulterated (21 U.S.C. 342(g)(1)). Additionally, Megaflora and Adrenal Refresh were found misbranded (21 U.S.C. § 343).

cGMP deficiencies included failure to verify dietary ingredient identity (21 CFR 111.75(a)(1)(i)), releasing finished products not meeting specifications (21 CFR 111.123(b)(2)), and improper management of out-of-specification components (21 CFR 111.77(a)). Master Manufacturing Records lacked corrective action plans (21 CFR 111.210(h)(5)), material review documentation was absent (21 CFR 111.140(b)(3)), and Batch Production Records were incomplete (21 CFR 111.255(b)). Quality control personnel also failed to approve written procedures (21 CFR 111.105(a)).

Misbranding issues for MegaFlora included undeclared Vitamin C (21 CFR 101.36(b)(2)). Adrenal Refresh had incorrect proprietary blend identification (21 CFR 101.36(c)), lacked botanical plant part identification (21 CFR 101.4(h)(1)), and omitted a domestic address/phone for adverse event reporting (21 U.S.C. § 343(y)). The firm also submitted a serious adverse event report late.

BioSan's responses were inadequate, lacking documentation of implemented corrective actions. The FDA requires a written response within 15 working days detailing corrective steps and preventative measures, with supporting documentation. Non-compliance may result in enforcement actions like seizure or injunction.

Company
BioSan Laboratories, Inc.
Inspection date
January 25, 2011
Product type
Food
Office
New England District Office
People
  • Mutahar Shamsi (District Director)
  • Todd J. Maushart
View Company Profile

ID · ce309676-442d-4a15-bd84-81454a1c25f3

Violation Codes10
21 U.S.C. 34321 U.S.C. 343(q)(5)(F)21 CFR 11121 U.S.C. 342(g)(1)21 CFR 111.75(a)(1)(i)21 CFR 111.123(b)(2)21 CFR 111.70(e)21 CFR 111.77(a)21 CFR 111.113(b)(2)21 CFR 111.210(h)(5)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore BioSan Laboratories, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.